Oncology & Cancer

Researchers identify new targets for immunotherapy in colon cancer

Colon cancer is one of the most common types of cancer. Particularly in advanced stages of disease, the treatment still largely relies on traditional chemotherapy. The new generation of cancer treatments, so-called immunotherapies, ...

Oncology & Cancer

Modeling the tumor micro-environment in the lab

For some types of cancer, the human body itself complicates adequate treatment. Connective tissue and the immune system then build a sort of "defensive wall" around the tumor, through which chemotherapy drugs cannot penetrate. ...

Oncology & Cancer

New biopsy technology for analyzing multiple tumor tissue biomarkers

A team led by University of California, Irvine researchers has developed a new biopsy technology that can profile multiple tumor microenvironment biomarkers simultaneously, revealing cellular spatial organization and interactions ...

Other

Sanofi to buy US biotech firm Amunix for $1 bn

French pharma giant Sanofi said Tuesday it had signed a billion-dollar deal to buy US-based biotech firm Amunix, which develops cancer treatments that enlist the body's immune system.

Inflammatory disorders

A more targeted therapy to treat inflammatory bowel disease

Biomedical scientists at the University of California, Riverside, propose a way for drugs to be more effective against inflammatory bowel disease, or IBD, in which the intestine undergoes inflammation.

page 10 from 40